We would like to introduce our company in Korea shortly. ISU Group, one of biggest conglomerates in Korea, established its biotechnology division with ambitious plans in 2001. At the same time, the Group set up PETAGEN INC., an affiliate specialized in research and medical service at Yonsei University for clinical trials in March, 2001. The company is eager to meet the unmet needs of customers by providing GTS (genetic test service) and customized CRA (chemotherapy response assay) services and developing novel targets with antibody proteomics technologies.

PETAGEN has released its IVD products on the market late 2004 after its entry into the IVD market. In November 2004, PETAGEN merged with the division to become ISU ABXIS CO., LTD. to emerge as an antibody-specialized company. IVD part at ISU ABXIS, as the manufacturer and exporter of IVD products for human and vet. OEM Service:
No. of R&D Staff:
Estimated Annual Sales (USD): US$5 Million - US$10 Million
Export Percentage:
Quality Control:
Legal Representative/CEO:
Factory Size (Sq.meters):
Factory Location:
Corporate Status:

Business Type: Year Established: 2001 Number of Employees: Legal Representative / CEO: Chang-Hoon, Choi Website: Certificates: Brands: Trade & Market Main Markets: Main Customers: Export Percentage: Trade Shows: Factory Information Factory Size (Sq.meters): Factory Location: QA/QC: Number of Production Lines: Number of R&D Staff: Contract Manufacturing: